- The Fed Is Boxed In. What It Means for Investors. (Barron’s)
- Soaring Oil and Gas Prices Boost BP Profit in the Shadow of COP26 (Barron’s)
- Intel Chairman Omar Ishrak and Other Insiders Bought $2 Million in Stock (Barron’s)
- 100 million Barrels and Counting. The Energy Report 11/02/2021 (Phil Flynn)
- Mortgage Bond Sales Surged in October (Wall Street Journal)
- The U.S. and EU Shake Up Global Trade (Wall Street Journal)
- Amazon to Launch First Two Internet Satellites in 2022 (New York Times)
- S&P 500 performance in 2022 will be bullish if history is a guide (asiamarkets)
- Wall Street Warns Bond Market Rout Will Catch Up With Stocks (Bloomberg)
- J&J, Teva Beat $50 Billion Opioid Case in First Industry Win (Bloomberg)
- One Trader Calls All the Shots in the Treasury Bond Market (Bloomberg)
- Bond Whiplash Raises Risk of a Financial Market Accident (Bloomberg)
- Small caps kick off November with a rally — why that’s good news for the S&P 500 (CNBC)
- Beijing’s flights are cancelled as China’s capital city tightens Covid restrictions (CNBC)
- China’s coal shortage eases after Beijing steps in, report says (CNBC)
- Bank of America names 13 stocks that are primed to rebound by January after underperforming this year due to tax-loss harvesting (businessinsider)
- Stocks are in ‘melt-up’ mode and have further to run before hitting a top as strong participation drives latest rally, Leuthold CIO says (businessinsider)
- Value investing legend John Rogers told us 4 stocks he’s been buying for the market’s next phase — and why the meme stock and bitcoin rallies remind him of a mistake he made in his earliest days (businessinsider)
- Signs of a new capex cycle’ emerge as S&P 500 companies report earnings, says BofA (marketwatch)
- Opinion: Higher interest rates probably won’t cause this bull market in stocks to end, according to research dating to 1871 (marketwatch)
- Clorox (CLX) Stock Gains 5% Following Q1 EPS Beat, Reaffirmed 2022 Outlook (streetinsider)
- Evercore ISI Reiterates Uber (UBER) as No.1 Mega Cap Pick Ahead of Earnings (streetinsider)
- Pfizer raises 2021 sales forecast for Covid vaccine to $36bn (Financial Times)
- US bond tumult risks triggering stock market volatility, analysts warns (Financial Times)